[Double-blind comparative study of roxithromycin (RU 28965) and midecamycin acetate (MOM) in the treatment of pneumonia].

R Soejima; Y Niki; J Hino; T Kishimoto; Y Nakagawa; M Sumi; A Saito; I Nakayama; M Tomizawa; Y Hiraga

doi:10.11150/kansenshogakuzasshi1970.63.501

[Double-blind comparative study of roxithromycin (RU 28965) and midecamycin acetate (MOM) in the treatment of pneumonia].

NobleID: NI6P59W91R47S84
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/CFC9AF57

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CFC9AF57.svg?ark=w1%2F20260515%2FCFC9AF57&value=id)](https://nobleid.org/work/w1/20260515/CFC9AF57)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

[Double-blind comparative study of roxithromycin (RU 28965) and midecamycin acetate (MOM) in the treatment of pneumonia].

NobleID: NI6P59W91R47S84
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/CFC9AF57

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CFC9AF57.svg?ark=w1%2F20260515%2FCFC9AF57&value=id)](https://nobleid.org/work/w1/20260515/CFC9AF57)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work